Supriya Lifescience Limited Capital Reinvestment Ratio

Latest as of September 2025: 0.76x

Supriya Lifescience Limited capital reinvestment ratio. Supriya Lifescience Limited (SUPRIYA) has a Capital Reinvestment Ratio of 0.76x as of September 2025, meaning it reinvests 1% of its operating cash flow (Rs555.65 Million) in capital expenditures (Rs422.49 Million). Check total reinvestment intensity of Supriya Lifescience Limited to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.76x
Capex / Operating Cash Flow

Operating Cash Flow

Rs555.65 Million
INR

Capital Expenditures

Rs422.49 Million
INR

Data as of

Sep 2025
Most recent filing

Capital Reinvestment Ratio of Supriya Lifescience Limited (2018–2025)

Capital reinvestment ratio of Supriya Lifescience Limited from 2018 to 2025. This chart tracks Supriya Lifescience Limited's Capital Reinvestment Ratio across 8 annual periods. Also explore Supriya Lifescience Limited annual equity growth to track the company's year-over-year net asset growth rate.

Supriya Lifescience Limited Capital Reinvestment Ratio by Year (2018–2025)

Supriya Lifescience Limited capital reinvestment ratio by year from 2018 to 2025. For the full cash flow conversion analysis, see SUPRIYA cash flow conversion.

Year Reinvestment Ratio Operating CF (INR) Capital Expenditures YoY Change
2025 0.94x Rs1.73 Billion Rs1.62 Billion ▼ -26.8%
2024 1.29x Rs1.13 Billion Rs1.46 Billion ▼ -21.5%
2023 1.64x Rs661.87 Million Rs1.08 Billion ▲ +33.4%
2022 1.23x Rs488.01 Million Rs599.04 Million ▲ +103.4%
2021 0.60x Rs799.30 Million Rs482.41 Million ▲ +185.6%
2020 0.21x Rs1.16 Billion Rs245.25 Million ▲ +48.1%
2019 0.14x Rs486.72 Million Rs69.45 Million ▼ -49.5%
2018 0.28x Rs174.52 Million Rs49.30 Million —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow